Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 19/20 | 0.93 |
| ▸ | AVPR2 | P30518 | 17/20 | 0.93 |
| ▸ | AVPR1B | P47901 | 12/20 | 0.93 |
| ▸ | AVPR1A | P37288 | 15/20 | 0.92 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29409445 | 0.91 | OXTR (1.00) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL29833233 | 0.91 | OXTR (1.00) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL15576363 | 0.90 | OXTR (0.88) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL17481295 | 0.89 | OXTR (0.74) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL12879226 | 0.87 | OXTR (0.89) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL15576202 | 0.86 | OXTR (0.89) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL12879222 | 0.86 | OXTR (0.89) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL15576367 | 0.85 | OXTR (0.88) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL15576204 | 0.84 | OXTR (0.89) | OXTRAVPR2AVPR1BAVPR1A | |
| SCHEMBL15576203 | 0.84 | OXTR (0.89) | OXTRAVPR2AVPR1BAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066132-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS AG (CH) | 2024-02-29 | — | — | US | disclosed |
| US-11752211-B2 | Fatty acids and their use in conjugation to biomolecules | NOVARTIS AG (CH) | 2023-09-12 | — | — | US | disclosed |
| US-20210000964-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2021-01-07 | — | — | US | disclosed |
| US-10786576-B2 | Fatty acids and their use in conjugation to biomolecules | NOVARTIS AG (CH) | 2020-09-29 | — | — | US | disclosed |
| US-20160030585-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS AG (CH) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160030585-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | FABP1, FABP2, FABP3 | OXTR 4146/4885AVPR2 1691/4885AVPR1B 2629/4885 |
| US-20240066132-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | FABP1, FABP2, FABP3 | OXTR 4146/4885AVPR2 1691/4885AVPR1B 2629/4885 |
| US-11752211-B2 | Fatty acids and their use in conjugation to biomolecules | FABP1, FABP2, FABP3 | OXTR 4133/4885AVPR2 1599/4885AVPR1B 2664/4885 |
| US-10786576-B2 | Fatty acids and their use in conjugation to biomolecules | FABP1, FABP2, FABP3 | OXTR 4133/4885AVPR2 1599/4885AVPR1B 2664/4885 |
| US-20210000964-A1 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | FABP1, FABP2, FABP3 | OXTR 4146/4885AVPR2 1691/4885AVPR1B 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.